m+Medelevator.RU
← Поиск публикаций
Archives of microbiology · 2026

Synthesis of biocompatible novel multi-tailed indole-based resorcinarene for effective delivery of quercetin against multidrug-resistant S. aureus.

СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Rehman Khadija, Kanwal Tasmina, Hasnain Muhammad, Maharjan Rukesh, Muzafar Wajeeha, Rao Komal, Saifullah Salim, Simjee Shabana Usman, Shah Muhammad Raza

Аннотация

Resorcine-based macrocycles have received significant attention in drug delivery applications owing to their tunable functional groups, well-defined cavities, and inherent self-assembly behavior, considering essential for encapsulation and controlled release of loaded drug candidates. However, existing resorcinarene derivatives face certain limitations in drug loading, physiologic stability, and compatibility with structurally complex natural therapeutics, necessitating the development of novel macrocyclic architectures with improved stability and compatibility for hydrophobic drugs. To address this gap, the current research synthesized a novel resorcinarene-based macrocycle, referred to as Indole Macrocycle (IM), to improve the therapeutic potential of quercetin (QTN). The synthesized IM was characterized utilizing Mass, 1H- and 13C-NMR, and FT-IR spectroscopy. Biocompatibility studies indicated high cell viability of NIH-3T3 cells at 30 µM (95.72 ± 0.4% at 24 h and 94.10 ± 0.3% at 48 h) and low hemolytic activity (9.32% ± 1.65% at 1000 µg/mL). The critical micelle concentration (CMC) of IM was determined to be 0.022 mM. QTN-loaded IM vesicles exhibited a spherical morphology with a size of 248.7 ± 7.17 nm, zeta potential of - 15.8 ± 0.8 mV, PDI of 0.258 ± 0.05, and encapsulation efficiency of 74 ± 2.57%, while demonstrating a controlled drug release profile, with maximum release of 69% ± 1.8% over 48 h. Antibacterial evaluation against multidrug-resistant S. aureus strains (NCTC 13143 and NCTC 13277) revealed a significantly reduced MIC of 170 ± 8.23 µg/mL compared to 488 ± 9.53 µg/mL for free QTN. The results were further confirmed through AFM analysis, demonstrating significant bacterial membrane disruption following treatment. These findings revealed that QTN-loaded IM vesicles are a promising system for improving drug delivery and combating MDR bacterial infections.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты